01.08.2010 | Research Articles
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias
Erschienen in: Clinical and Translational Oncology | Ausgabe 8/2010
Einloggen, um Zugang zu erhalten